175 related articles for article (PubMed ID: 18816529)
21. Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms.
dos Santos JL; Lanaro C; Lima LM; Gambero S; Franco-Penteado CF; Alexandre-Moreira MS; Wade M; Yerigenahally S; Kutlar A; Meiler SE; Costa FF; Chung M
J Med Chem; 2011 Aug; 54(16):5811-9. PubMed ID: 21766854
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
Patwa DC; Abraham DJ; Hung TC
Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
[TBL] [Abstract][Full Text] [Related]
23. How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium.
Abraham DJ; Safo MK; Boyiri T; Danso-Danquah RE; Kister J; Poyart C
Biochemistry; 1995 Nov; 34(46):15006-20. PubMed ID: 7578114
[TBL] [Abstract][Full Text] [Related]
24. Substituted benzaldehyde thiosemicarbazone with antiviral activity against poliovirus.
Andrei GM; Pieroni OI; Gatica HS; Coto CE
Drugs Exp Clin Res; 1985; 11(12):869-73. PubMed ID: 3013560
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids.
Fatope MO; Abraham DJ
J Med Chem; 1987 Nov; 30(11):1973-7. PubMed ID: 3669005
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and anti-migrative evaluation of moverastin derivatives.
Sawada M; Kubo S; Matsumura K; Takemoto Y; Kobayashi H; Tashiro E; Kitahara T; Watanabe H; Imoto M
Bioorg Med Chem Lett; 2011 Mar; 21(5):1385-9. PubMed ID: 21306898
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
Abraham DJ; Kennedy PE; Mehanna AS; Patwa DC; Williams FL
J Med Chem; 1984 Aug; 27(8):967-78. PubMed ID: 6747995
[TBL] [Abstract][Full Text] [Related]
28. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN
Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893
[TBL] [Abstract][Full Text] [Related]
29. Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists.
Kishino H; Moriya M; Sakuraba S; Sakamoto T; Takahashi H; Suzuki T; Moriya R; Ito M; Iwaasa H; Takenaga N; Ishihara A; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Aug; 19(16):4589-93. PubMed ID: 19615899
[TBL] [Abstract][Full Text] [Related]
30. Condensation of 1-(4,4-dimethyl-2-piperidon-6-yl)-2-propanone with benzaldehyde derivatives.
Czuba W; Sedzik-Hibner D; Tatarczyńska E
Pol J Pharmacol Pharm; 1984; 36(6):705-13. PubMed ID: 6535160
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of pyridine derivatives of L-phenylalanine as antisickling reagents.
Altman J; Gorecki M; Wilchek M; Votano JR; Rich A
J Med Chem; 1984 May; 27(5):596-600. PubMed ID: 6716398
[TBL] [Abstract][Full Text] [Related]
32. Specific chemical modifications in the beta-cleft site of hemoglobin. Potential anti-sickling agents with hybrid functionalities.
Klotz IM; Haney DN; Wood LE
J Biol Chem; 1985 Dec; 260(30):16215-23. PubMed ID: 4066708
[TBL] [Abstract][Full Text] [Related]
33. NHC-promoted asymmetric β-lactone formation from arylalkylketenes and electron-deficient benzaldehydes or pyridinecarboxaldehydes.
Douglas J; Taylor JE; Churchill G; Slawin AM; Smith AD
J Org Chem; 2013 Apr; 78(8):3925-38. PubMed ID: 23442090
[TBL] [Abstract][Full Text] [Related]
34. [Effects of 3 varieties of antisickling substances measured by ektacytometry as a function of oxygen pressure].
Feo CJ; Johnson RM; Nossal M
C R Seances Acad Sci III; 1983; 296(19):911-6. PubMed ID: 6412992
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of the in-vitro binding kinetics of antisickling aromatic aldehydes with hemoglobin A: A universal HPLC-UV/Vis method to quantitate Schiff-base adduct formation.
Xu X; Ghatge MS; Huang B; Alghamdi A; Wang H; Pierce BD; Abdulmalik O; Zhang Y; Safo MK; Venitz J
J Pharm Biomed Anal; 2023 Jan; 223():115152. PubMed ID: 36399908
[TBL] [Abstract][Full Text] [Related]
36. Use of citrate agar electrophoresis in evaluation of antisickling agents.
Wilson E; Winter WP
J Natl Med Assoc; 1981 Feb; 73(2):111-6. PubMed ID: 7205973
[TBL] [Abstract][Full Text] [Related]
37. High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
Safo MK; Moure CM; Burnett JC; Joshi GS; Abraham DJ
Protein Sci; 2001 May; 10(5):951-7. PubMed ID: 11316875
[TBL] [Abstract][Full Text] [Related]
38. Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
Mai A; Valente S; Meade S; Carafa V; Tardugno M; Nebbioso A; Galmozzi A; Mitro N; De Fabiani E; Altucci L; Kazantsev A
J Med Chem; 2009 Sep; 52(17):5496-504. PubMed ID: 19663498
[TBL] [Abstract][Full Text] [Related]
39. Novel vanillin derivatives: Synthesis, anti-oxidant, DNA and cellular protection properties.
Scipioni M; Kay G; Megson I; Kong Thoo Lin P
Eur J Med Chem; 2018 Jan; 143():745-754. PubMed ID: 29220795
[TBL] [Abstract][Full Text] [Related]
40. Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo.
Lirdprapamongkol K; Kramb JP; Suthiphongchai T; Surarit R; Srisomsap C; Dannhardt G; Svasti J
J Agric Food Chem; 2009 Apr; 57(8):3055-63. PubMed ID: 19368348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
